Clinical trial
A Prospective Phase 1 Trial of Cardiac Progenitor Cell Therapy in Children With Dilated Cardiomyopathy
NCT03129568 is registered in ClinicalTrials.gov with Okayama University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Phase 1 Trial of Cardiac Progenitor Cell Therapy in Children With Dilated Cardiomyopathy
- Lead sponsor
- Okayama University
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- April 14, 2017
- Completion date
- December 9, 2020
- Enrollment
- 5 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
dilated cardiomyopathy